PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS

被引：0
|
作者：
Boven, E. [1 ]
Massard, C. [2 ]
Armand, J. P. [3 ]
Tillier, C. [1 ]
Hartog, V. [1 ]
Brega, N. M. [4 ]
Contouriotis, A. M. [5 ]
Law, C. N. J. [5 ]
Soria, J. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Inst Gustave Roussy, Villejuif, France
[3] Inst Claudius Regaud, Toulouse, France
[4] Pfizer Global Res & Dev, Oncology, Milan, Italy
[5] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [11] Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
    Chow, L. Q.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    Goss, G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [12] A PHASE I DOSE ESCALATION STUDY OF SUNITINIB (SU) IN COMBINATION WITH PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID MALIGNANCIES
    Chow, L. Q. M.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [13] Ifosfamide and irinotecan in solid tumors:: A phase I dose-finding trial
    Moyano, AJ
    Seguí, MA
    Abad, T
    Urruticoechea, L
    López, JLG
    Nogué, M
    Dominguez, MS
    Balcells, M
    Dorado, JF
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 3 - 7
  • [14] Phase I Dose-Finding Study for Pazopanib (P) and Paclitaxel (T) in Combination in the First-line Setting in Patients (pts) With Advanced Solid Tumours
    Kendra, K.
    Plummer, R.
    Salgia, R.
    O'Brien, M. E. R.
    Paul, E. M.
    Suttle, A. B.
    Ottesen, L. H.
    Villalona-Calero, M. A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S146 - S146
  • [15] A PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH CISPLATIN (P) AND 5-FLUOROURACIL (5-FU) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (GC)
    Gomez-Martin, C.
    Gil-Martin, M.
    Montagut, C.
    Nunez, J. A.
    Salazar, R.
    Puig, M.
    Khosravan, R.
    Tursi, J. M.
    Lechuga, M. J.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 255 - 255
  • [16] Biweekly vinorelbine and gemcitabine:: a phase I dose-finding study in patients with advanced solid tumors
    Castellano, D
    Hitt, R
    Ciruelos, E
    Cortés-Funes, H
    Colomer, R
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 783 - 787
  • [17] A phase I dose-finding study of pemetrexed combined with paclitaxel in patients with advanced solid tumors
    Bolling, C.
    Luebbing, C.
    Graefe, T.
    Mueler-Hagen, S.
    Leisner, B.
    Blatter, J.
    Hanauske, A.-R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 421 - 421
  • [18] Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.
    Sessa, C.
    Gallerani, E.
    Del Conte, G.
    Christinat, A.
    Perotti, A.
    Lardelli, P.
    Kahatt, C. M.
    Florez, A.
    Fernandez, C.
    Miani, M.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [19] A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer
    Gomez-Martin, C.
    Salazar, R.
    Montagut, C.
    Gil-Martin, M.
    Nunez, J. A.
    Puig, M.
    Lin, X.
    Khosravan, R.
    Tursi, J. M.
    Lechuga, M. J.
    Bellmunt, J.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (02) : 390 - 398
  • [20] Phase I study of sunitinib (SU) in combination with pemetrexed (Pem) in patients (pts) with advanced solid tumors (ST)
    Nakagawa, K.
    Okamoto, I.
    Shimizu, T.
    Miyazaki, M.
    Tsurutani, J.
    Ichikawa, Y.
    Terashima, M.
    Takeda, M.
    Fumita, S.
    Kiriyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345